Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Sarcoidosis

Explore clinical trials studying Pulmonary Sarcoidosis. Study availability and eligibility vary by location and protocol.

21 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Sarcoidosis trial results

Recruiting

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

NCT05890729

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Xentria Investigative Site Birmingham, Alabama, United States
  • Xentria Investigative Site Denver, Colorado, United States
  • Xentria Investigative Site Jacksonville, Florida, United States
  • Xentria Investigative Site Chicago, Illinois, United States
View all 34 locations
View Trial Details
Recruiting

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

NCT06205121

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Molecure Investigative Site Birmingham, Alabama, United States
  • Molecure Investigative Site Kansas City, Kansas, United States
  • Molecure Investigative Site Baltimore, Maryland, United States
  • Molecure Investigative Site Rochester, Minnesota, United States
View all 28 locations
View Trial Details
Enrolling by Invitation

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

NCT06169397

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Xentria Investigative Site Denver, Colorado, United States
  • Xentria Investigative Site Chicago, Illinois, United States
  • Xentria Investigative Site Greenville, North Carolina, United States
  • Xentria Investigative Site Cincinnati, Ohio, United States
View Trial Details
Completed

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

NCT05415137

Conditions
Fibrosis, Granuloma, Hemic and Lymphatic Diseases, +15 more
Locations
  • aTyr Investigative Site Birmingham, Alabama, United States
  • aTyr Investigative Site Phoenix, Arizona, United States
  • aTyr Investigative Site Los Angeles, California, United States
  • aTyr Investigative Site Sacramento, California, United States
View all 91 locations
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

NCT04064242

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Univ of Florida College of Medicine x Gainesville, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • John Hopkins Asthma And Alrgy Cntr Baltimore, Maryland, United States
View all 22 locations
View Trial Details

Related conditions